Tapestry Pharmaceuticals, Inc.

(NASDAQ:TPPH)
  Sep 30, 2007
Cash Flow Statement
Cash At Beginning Of Period 180
Cash At End Of Period 5,577
Net Change In Cash And Cash Equivalents 5,397
Effect Of Exchange Rate Changes
Net Income Or Loss -16,681
Cash From Operating Activities
Depreciation Expenses 173
Amortization Expenses -54
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables
Increase Or Decrease In Inventories
Increase Or Decrease In Prepaid Expenses -255
Increase Or Decrease In Other Current Assets -255
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities 1,212
Increase Or Decrease In Other Working Capital -138
Other Non Cash Items
Net Cash From Continuing Operations 2,892
Net Cash From Discontinued Operations -12,851
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -199
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments -13,656
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 18,345
Cash From Financing Activities
Issuance Of Debt
Issuance Of Capital Stock -97
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends
Net Other Financing Charges
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -97